Diastolic blood pressure predicts coronary plaque volume in patients with coronary artery disease

Mohamad Saleh1, Abdulhamied Alfaddagh1, Tarec K Elajami1

  • 1Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.

Atherosclerosis
|September 1, 2018
PubMed

Insights

Lower diastolic blood pressure (DBP) is linked to reduced coronary plaque volume in patients with stable coronary artery disease (CAD). This finding highlights DBP as a key factor in predicting atherosclerosis progression.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Hypertension is a known risk factor for coronary artery disease (CAD).
  • The precise relationship between blood pressure levels and the volume of coronary atherosclerotic plaque remains incompletely understood.
  • Understanding this link is crucial for managing CAD risk.

Purpose of the Study:

  • To investigate the association between systolic blood pressure (SBP) and diastolic blood pressure (DBP) and the volume of coronary plaque.
  • To determine if specific blood pressure parameters predict plaque burden in patients with established CAD.

Main Methods:

  • Coronary computed tomographic angiography (CCTA) was performed on 285 patients with stable CAD receiving statin therapy.
  • CCTA was used to quantify the volumes of different plaque types: fatty, fibrous, noncalcified, and calcified.
  • Blood pressure measurements (SBP and DBP) were analyzed in relation to plaque volumes.

Main Results:

  • Lower diastolic blood pressure (DBP) tertiles were associated with significantly lower volumes of fatty, fibrous, noncalcified, and total coronary plaque compared to the highest DBP tertile.
  • Systolic blood pressure (SBP) levels did not show a significant association with coronary plaque volume.
  • Higher DBP was identified as an independent predictor of increased plaque volume across all plaque types after multivariate adjustment.

Conclusions:

  • Diastolic blood pressure (DBP) is a significant predictor of coronary plaque volume in patients with stable CAD.
  • Lower DBP levels, particularly below 68 mmHg, are associated with the least amount of coronary plaque, especially in patients with controlled LDL-C levels (< 80 mg/dL).
  • These findings suggest that DBP management may be important for controlling atherosclerosis progression.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
480
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
276
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
385
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
699
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.3K